Identify the Predictors of Antibiotic ResistanceNCT06750744
Predictors of Antimicrobial Resistance in the Respiratory Intensive Care Unit of Alexandria Main University Hospital
An observational study of Identify the Predictors of Antibiotic Resistance, run by Mohamed Sabry at 1 site in Egypt.
Trial summary
The goal of this clinical trial is to identify the predictors of antibiotic resistance whether clinical or laboratory or radiological or all Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Identify the Predictors of Antibiotic Resistance
- What is being tested?
- chest x ray and Tigecycline (Tygacil)
- Type of treatment
- Surgery or procedure
- How many people
- 50 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Oct 2024to 12 Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The current study aims to identify the predictors of antibiotic resistance in the respiratory intensive care unit of Alexandria main university hospital
Who may be able to join
- Adult patient admitted to the respiratory ICU due to bacterial infection.
- Recent antibiotic intake in the past three months.
- Intercostal tube insertion for empyema.
- Shocked patients with inserted central venous catheter.
- Intubated or tracheostomized patients.
- Patients with grade two to four bed sores.
Who cannot join
- . Inability to provide written informed consent for the study.
- Non sterile sample collection technique.
- Inability to provide antibiogram.
- Isolated patients due to suspected tuberculosis
Trial locations and contacts
1 site in 1 country.
About this study
The goal of this clinical trial is to identify the predictors of antibiotic resistance whether clinical or laboratory or radiological or all
Read the detailed description
The goal of this clinical trial is to identify the predictors of antibiotic resistance like the history of previous antibiotic ,the antibiogram of the centre , comorbidities,..etc to decide the suitable antibiotic
- Being tested
- chest x ray, Tigecycline (Tygacil)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
chest x rayRadiation
Also called antibiogram
chest X ray identify severity of pneumonia
chest X rayRadiation
chest radiological evaluation via x ray
Tigecycline (Tygacil)Drug
selective antibiogram
| Study group | Role | What they receive |
|---|---|---|
| only one group of patients | to identify the predictors of antibiotic resistance using rates of resistance,comprehensive data of each patient chest X ray,CT,ultrasound Receives: Radiation: chest x ray; Drug: Tigecycline (Tygacil) |
What is being measured
The primary outcome is the main question the study is designed to answer.
antibiogram
resistance rates in antibiograms
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Dec 2024
- Study start1 Oct 2024
- Primary completion11 Dec 2024
- Study completion12 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Identify the Predictors of Antibiotic ResistanceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mohamed Sabry
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Mohamed Sabry, Alexandria University
- Investigators
- mohamed sabry eltarhony, lecturer, Principal investigator, Alexandria University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06750744
- Sponsor's protocol ID
- AMR-AMUH
- Status last verified
- Dec 2024
- First submitted
- 20 Dec 2024
- Last updated
- 27 Dec 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- Yes
- FDA-regulated device
- Yes
- Individual data sharing
- No: because the facility, where i do my work, refuse to share any project untill it is fully published
Study at a glance
From the registry record, last updated by the sponsor on 27 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Predictors of Antimicrobial Resistance in the Respiratory Intensive Care Unit of Alexandria Main University Hospital
- ClinicalTrials.gov ID
- NCT06750744
- Acronym / sponsor ID
- AMR-AMUH
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Mohamed SabryUniversity, hospital or other
- Study start
- 1 Oct 2024 (actual)
- Primary completion
- 11 Dec 2024 (actual)
- Study completion
- 12 Dec 2024 (actual)
- First posted
- 27 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to identify the predictors of antibiotic resistance whether clinical or laboratory or radiological or all
Detailed description
The goal of this clinical trial is to identify the predictors of antibiotic resistance like the history of previous antibiotic ,the antibiogram of the centre , comorbidities,..etc to decide the suitable antibiotic
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| only one group of patients | – | Radiation: chest x ray, Drug: Tigecycline (Tygacil)to identify the predictors of antibiotic resistance using rates of resistance,comprehensive data of each patient chest X ray,CT,ultrasound |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The current study aims to identify the predictors of antibiotic resistance in the respiratory intensive care unit of Alexandria main university hospital
Key inclusion criteria (6 listed)
- Adult patient admitted to the respiratory ICU due to bacterial infection.
Key exclusion criteria (4 listed)
- . Inability to provide written informed consent for the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| chest x rayAlso: antibiogramchest X ray identify severity of pneumonia | Radiation | only one group of patients |
| chest X raychest radiological evaluation via x ray | Radiation | only one group of patients |
| Tigecycline (Tygacil)selective antibiogram | Drug | only one group of patients |
Primary outcome
antibiogram
Time frame: 3 months
resistance rates in antibiograms
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Dec 2024.
- antimicrobial resistancde predictionLink provided by the sponsor.
- Individual participant dataSharing planned: No. because the facility, where i do my work, refuse to share any project untill it is fully published
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
mohamed sabry eltarhony, lecturer principal investigator
Alexandria University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Identify the Predictors of Antibiotic Resistance, run by Mohamed Sabry at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
antibiogram (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2024.